Sensus Healthcare (SRTS) Competitors $5.51 -0.14 (-2.48%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$5.52 +0.02 (+0.27%) As of 07/25/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRTS vs. DRTS, NYXH, XAIR, SMTI, STIM, ZIMV, SKIN, TCMD, BWAY, and NVROShould you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Alpha Tau Medical (DRTS), Nyxoah (NYXH), Beyond Air (XAIR), Sanara MedTech (SMTI), Neuronetics (STIM), ZimVie (ZIMV), Beauty Health (SKIN), Tactile Systems Technology (TCMD), Brainsway (BWAY), and Nevro (NVRO). These companies are all part of the "medical equipment" industry. Sensus Healthcare vs. Its Competitors Alpha Tau Medical Nyxoah Beyond Air Sanara MedTech Neuronetics ZimVie Beauty Health Tactile Systems Technology Brainsway Nevro Sensus Healthcare (NASDAQ:SRTS) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability. Do institutionals & insiders have more ownership in SRTS or DRTS? 25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 8.9% of Sensus Healthcare shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has higher valuation & earnings, SRTS or DRTS? Sensus Healthcare has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.81M2.17$6.65M$0.1055.10Alpha Tau MedicalN/AN/A-$31.75M-$0.46-6.65 Do analysts prefer SRTS or DRTS? Sensus Healthcare presently has a consensus target price of $11.67, suggesting a potential upside of 111.74%. Alpha Tau Medical has a consensus target price of $8.00, suggesting a potential upside of 161.44%. Given Alpha Tau Medical's higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to SRTS or DRTS? In the previous week, Sensus Healthcare had 2 more articles in the media than Alpha Tau Medical. MarketBeat recorded 3 mentions for Sensus Healthcare and 1 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.89 beat Sensus Healthcare's score of 0.47 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment Sensus Healthcare Neutral Alpha Tau Medical Very Positive Is SRTS or DRTS more profitable? Sensus Healthcare has a net margin of 4.56% compared to Alpha Tau Medical's net margin of 0.00%. Sensus Healthcare's return on equity of 3.34% beat Alpha Tau Medical's return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare4.56% 3.34% 3.00% Alpha Tau Medical N/A -49.48%-36.69% Which has more volatility & risk, SRTS or DRTS? Sensus Healthcare has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. SummarySensus Healthcare beats Alpha Tau Medical on 11 of the 14 factors compared between the two stocks. Get Sensus Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRTS vs. The Competition Export to ExcelMetricSensus HealthcareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$92.91M$6.85B$5.70B$9.50BDividend YieldN/A1.27%4.60%4.01%P/E Ratio55.1025.4528.1020.05Price / Sales2.1764.09429.3789.38Price / Cash13.0820.5536.2258.56Price / Book1.624.758.665.87Net Income$6.65M$176.14M$3.25B$258.55M7 Day Performance26.96%2.92%4.22%3.73%1 Month Performance14.32%3.23%10.51%11.75%1 Year Performance-12.12%7.28%34.40%18.03% Sensus Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRTSSensus Healthcare1.1298 of 5 stars$5.51-2.5%$11.67+111.7%-13.1%$92.91M$41.81M55.1040News CoverageDRTSAlpha Tau Medical2.8448 of 5 stars$3.23+5.6%$8.00+147.7%+44.0%$273.97MN/A-7.0280High Trading VolumeNYXHNyxoah2.523 of 5 stars$7.84+3.7%$14.50+84.9%-10.6%$267.03M$4.36M-3.68110Positive NewsXAIRBeyond Air4.4725 of 5 stars$3.05-11.6%$1.50-50.8%-74.5%$263.43M$3.70M-3.8670Analyst UpgradeHigh Trading VolumeSMTISanara MedTech2.0107 of 5 stars$28.87-0.7%$49.50+71.5%-20.7%$256.65M$86.67M-21.5460Positive NewsHigh Trading VolumeSTIMNeuronetics1.4932 of 5 stars$3.86+8.1%$5.50+42.5%+137.6%$255.19M$74.89M-2.95180Positive NewsZIMVZimVie0.5308 of 5 stars$8.93-0.8%$16.33+82.9%-13.8%$248.67M$443.55M-12.581,770News CoverageAnalyst UpgradeSKINBeauty Health0.2077 of 5 stars$1.87-2.1%$1.42-24.2%-1.6%$235.61M$322.47M-4.561,030Gap UpTCMDTactile Systems Technology3.6431 of 5 stars$10.04+0.8%$16.00+59.4%-18.3%$233.43M$292.98M15.211,037Positive NewsBWAYBrainsway2.7702 of 5 stars$12.23-0.6%$14.25+16.5%+53.3%$231.15M$41.02M61.15120Positive NewsNVRONevroN/A$5.85+0.1%$5.36-8.3%-40.8%$224.32M$408.52M-3.091,090 Related Companies and Tools Related Companies DRTS Alternatives NYXH Alternatives XAIR Alternatives SMTI Alternatives STIM Alternatives ZIMV Alternatives SKIN Alternatives TCMD Alternatives BWAY Alternatives NVRO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRTS) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRTS Stock Alerts